Related Experiment Videos

Increased risk of peripheral arterial disease in polymyalgia rheumatica: a population-based cohort study

Kenneth J Warrington1, Elena P Jarpa, Cynthia S Crowson

  • 1Department of Medicine, Division of Rheumatology, Mayo Clinic, Rochester, MN 55905, USA. warrington.kenneth@mayo.edu

Abstract

Insights

Patients with polymyalgia rheumatica (PMR) have a significantly higher risk of developing peripheral arterial disease (PAD). This study confirms an increased PAD risk in PMR patients, even after accounting for other cardiovascular factors.

Area of Science:

  • Rheumatology
  • Cardiovascular Medicine
  • Epidemiology

Background:

  • Polymyalgia rheumatica (PMR) is an inflammatory condition.
  • The association between PMR and peripheral arterial disease (PAD) requires further investigation.

Purpose of the Study:

  • To determine if patients diagnosed with polymyalgia rheumatica (PMR) face an elevated risk of peripheral arterial disease (PAD).

Main Methods:

  • An inception cohort of PMR patients from Olmsted County, Minnesota, was compared to a control group.
  • Longitudinal follow-up via medical record review was conducted from diagnosis until 2006.
  • Cox proportional hazards models were employed to assess PAD risk in PMR patients versus controls.

Main Results:

  • Patients with PMR showed a significantly higher cumulative incidence of PAD compared to non-PMR subjects.
  • The adjusted hazard ratio for PAD in PMR patients was 2.50 (1.53, 4.08), indicating a 2.5-fold increased risk.
  • Giant cell arteritis, a related condition, did not predict PAD development in PMR patients.

Conclusions:

  • Polymyalgia rheumatica (PMR) is associated with an increased risk of peripheral arterial disease (PAD).
  • This finding highlights the importance of cardiovascular risk assessment in PMR patients.

Related Concept Videos

Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...